Health care startups that raised Series B
Updated 23 Oct 2026
2,750
Companies
$72.5B
Last round total
100
Rows shown
Latest rounds
Most recent round first
100 rows
| # | Company | Round | Amount | Date | City | Sector |
|---|---|---|---|---|---|---|
| 1 | Hyperway Pharm | Series B | $14.9M | 2026-10-15 | Chengdu | Health care |
| 2 | Prolific Machines | Series B | $50.0M | 2026-10-14 | Emeryville | Artificial intelligence |
| 3 | Soufflé Therapeutics | Series B | $135.0M | 2026-10-13 | Boston | Biotech |
| 4 | Scarlet | Series B | $50.0M | 2026-10-12 | London | Artificial intelligence |
| 5 | Boldfit | Series B | $41.7M | 2026-10-12 | bangalore-karnataka | Commerce |
| 6 | Moxian Technology | Series B | 2026-10-10 | Dongguan | Hardware | |
| 7 | Sava Technology | Series B | $36.0M | 2026-10-09 | London | Biotech |
| 8 | RadioNano Therapeutics | Series B | $955K | 2026-10-09 | Kyoto | Biotech |
| 9 | Matchpoint Therapeutics | Series B | $150.0M | 2026-10-07 | Cambridge | Biotech |
| 10 | East Africa Fruits | Series B | $26.0M | 2026-10-07 | Dar Es Salaam | Commerce |
| 11 | General Medicine | Series B | $120.0M | 2026-10-06 | San Francisco | Health care |
| 12 | KymaThera | Series B | $80.0M | 2026-10-06 | San Diego | Biotech |
| 13 | Multiply Labs | Series B | $75.0M | 2026-10-06 | San Francisco | Artificial intelligence |
| 14 | Celaid Therapeutics | Series B | $2.5M | 2026-10-05 | Tokyo | Biotech |
| 15 | hiyo | Series B | $20.8M | 2026-10-02 | Los Angeles | Health care |
| 16 | AnaCardio | Series B | $70.8M | 2026-09-30 | Solna | Biotech |
| 17 | Astrocyte Pharmaceuticals | Series B | $9.5M | 2026-09-30 | Groton | Biotech |
| 18 | Tiny Health | Series B | $33.0M | 2026-09-29 | Austin | Biotech |
| 19 | NexThera | Series B | $16.2M | 2026-09-28 | Jungang | Biotech |
| 20 | HITS | Series B | $13.5M | 2026-09-28 | Seoul | Artificial intelligence |
| 21 | ALPFA Medical | Series B | $30.0M | 2026-09-25 | Palo Alto | Biotech |
| 22 | Bluesail Surgical | Series B | $104.5M | 2026-09-23 | Shanghai | Biotech |
| 23 | UltraSight | Series B | $24.0M | 2026-09-23 | Cambridge | Health care |
| 24 | Vapo Health | Series B | $7.5M | 2026-09-23 | Kunshan | Biotech |
| 25 | Aqua Medical | Series B | 2026-09-23 | Pleasanton | Biotech | |
| 26 | Incepto Medical | Series B | $16.0M | 2026-09-22 | Paris | Artificial intelligence |
| 27 | Zhiran Medical | Series B | $89.6M | 2026-09-21 | Beijing | Health care |
| 28 | Qiantang Longyue | Series B | $14.9M | 2026-09-17 | Hangzhou | Biotech |
| 29 | FIZE Medical | Series B | $6.0M | 2026-09-17 | Tel Aviv | Artificial intelligence |
| 30 | Maybio Matrix | Series B | 2026-09-17 | Chaoyang | Biotech | |
| 31 | Evvy | Series B | $40.0M | 2026-09-15 | New York | Artificial intelligence |
| 32 | Tandem Health | Series B | $100.0M | 2026-09-14 | Stockholm | Artificial intelligence |
| 33 | Vibronix | Series B | $14.9M | 2026-09-14 | West Lafayette | Artificial intelligence |
| 34 | Shenzhen Yurucheng | Series B | 2026-09-11 | Shenzhen | Health care | |
| 35 | DermaSensor | Series B | $4.0M | 2026-09-09 | Miami | Artificial intelligence |
| 36 | Moonwalk Biosciences | Series B | $70.0M | 2026-09-08 | South San Francisco | Artificial intelligence |
| 37 | MVRIX | Series B | $5.9M | 2026-09-04 | Seoul | Biotech |
| 38 | NeuShen Therapeutics | Series B | $80.0M | 2026-09-03 | Shanghai | Biotech |
| 39 | Superluminal Medicines | Series B | $65.5M | 2026-09-03 | Boston | Artificial intelligence |
| 40 | David | Series B | $250.0M | 2026-09-02 | New York | Health care |
| 41 | Medici Brands | Series B | $250.0M | 2026-09-02 | New York | Health care |
| 42 | Medefa | Series B | $14.9M | 2026-09-02 | Zhuhai | Biotech |
| 43 | N-Power Medicine | Series B | $32.0M | 2026-09-01 | Redwood City | Artificial intelligence |
| 44 | NovaGo Therapeutics | Series B | $29.7M | 2026-08-31 | Schlieren | Biotech |
| 45 | Yuce Biotechnology | Series B | $7.4M | 2026-08-31 | Suzhou | Biotech |
| 46 | Faro AI | Series B | $37.3M | 2026-08-26 | San Diego | Artificial intelligence |
| 47 | MileBot Robotics | Series B | $14.9M | 2026-08-26 | Shenzhen | Artificial intelligence |
| 48 | Arintra | Series B | $25.0M | 2026-08-21 | Austin | Artificial intelligence |
| 49 | Xiaocheng Changnu | Series B | $14.5M | 2026-08-21 | Tianjin | Fintech |
| 50 | Butterfly Learnings | Series B | $6.8M | 2026-08-19 | Thane | Health care |
| 51 | Simnova | Series B | $59.3M | 2026-08-18 | Cambridge | Biotech |
| 52 | Georgiamune | Series B | $92.7M | 2026-08-17 | Gaithersburg | Biotech |
| 53 | Leadinno Medical Valley | Series B | $29.7M | 2026-08-17 | Beijing | Health care |
| 54 | Khartis Therapeutics | Series B | $50.0M | 2026-08-13 | San Diego | Biotech |
| 55 | Hongxin Biology | Series B | $14.0M | 2026-08-13 | Shenzhen | Biotech |
| 56 | InduPro | Series B | $77.0M | 2026-08-12 | Seattle | Biotech |
| 57 | Amplifica | Series B | $26.0M | 2026-08-12 | San Diego | Biotech |
| 58 | Vaderis Therapeutics | Series B | $152.0M | 2026-08-11 | Basel | Biotech |
| 59 | Flagler Health | Series B | $50.0M | 2026-08-11 | New York | Artificial intelligence |
| 60 | Aureka Biotechnologies | Series B | $100.0M | 2026-08-10 | Laguna Hills | Artificial intelligence |
| 61 | Notable Systems | Series B | $18.1M | 2026-08-10 | Denver | Artificial intelligence |
| 62 | Awexome Ray | Series B | $5.3M | 2026-08-10 | Seongnam | Health care |
| 63 | Meduloc | Series B | $4.0M | 2026-08-06 | Del Mar | Health care |
| 64 | Expedition Therapeutics | Series B | $115.0M | 2026-08-05 | San Francisco | Biotech |
| 65 | Mironid | Series B | $45.9M | 2026-08-05 | Glasgow | Biotech |
| 66 | ADVATEC | Series B | $1.0M | 2026-08-05 | Shibuya | Artificial intelligence |
| 67 | QuantHealth | Series B | $45.0M | 2026-08-04 | Tel Aviv | Artificial intelligence |
| 68 | Theradaptive | Series B | $36.2M | 2026-08-04 | Frederick | Biotech |
| 69 | Wellinks (formerly Convexity Scientific) | Series B | $10.0M | 2026-08-04 | New Haven | Health care |
| 70 | Health Plus | Series B | 2026-08-03 | Beijing | Fintech | |
| 71 | MediQStar | Series B | 2026-08-03 | Seongnam | Artificial intelligence | |
| 72 | Qureight | Series B | $20.0M | 2026-07-29 | Cambridge | Artificial intelligence |
| 73 | Claris Biotherapeutics | Series B | $118.0M | 2026-07-28 | Jersey City | Biotech |
| 74 | SenseTime | Series B | $100.0M | 2026-07-28 | Shanghai | Artificial intelligence |
| 75 | Epitel | Series B | $26.0M | 2026-07-28 | Salt Lake City | Artificial intelligence |
| 76 | Layerwave Bio | Series B | $13.8M | 2026-07-28 | Daxing | Biotech |
| 77 | Crystalys Therapeutics | Series B | $130.0M | 2026-07-22 | San Diego | Biotech |
| 78 | Hilo by Aktiia | Series B | $19.0M | 2026-07-22 | Neuchâtel | Artificial intelligence |
| 79 | Hilo | Series B | $19.0M | 2026-07-21 | Neuchâtel | Health care |
| 80 | RapidPulse | Series B | $48.0M | 2026-07-16 | Miami | Health care |
| 81 | Bunkerhill Health | Series B | $25.0M | 2026-07-16 | Palo Alto | Artificial intelligence |
| 82 | Draig Therapeutics | Series B | $65.0M | 2026-07-14 | Cardiff | Biotech |
| 83 | Illuminare Biotechnologies | Series B | $2.4M | 2026-07-14 | Princeton | Biotech |
| 84 | Huaxia Yuan Group | Series B | 2026-07-14 | Minhang | Biotech | |
| 85 | MindRank AI | Series B | $52.0M | 2026-07-08 | Shanghai | Artificial intelligence |
| 86 | Sonosemi Medical | Series B | $27.3M | 2026-07-08 | Shenzhen | Health care |
| 87 | Pediatrica | Series B | $28.0M | 2026-07-07 | Miami | Health care |
| 88 | Handspring Health | Series B | $19.0M | 2026-07-07 | Newark | Health care |
| 89 | Kuehnle Agrosystems | Series B | $3.0M | 2026-07-06 | Honolulu | Biotech |
| 90 | BLXCKSTONE | Series B | $10.0M | 2026-07-04 | Beverly Hills | Fintech |
| 91 | Pyrotech | Series B | 2026-07-03 | Changping | Biotech | |
| 92 | Emoha Elder Care | Series B | $8.9M | 2026-07-02 | Haryana | Health care |
| 93 | LASO Biotech | Series B | $14.0M | 2026-07-01 | Beijing | Health care |
| 94 | Materna Medical | Series B | $5.0M | 2026-07-01 | Mountain View | Health care |
| 95 | Inocras | Series B | $20K | 2026-07-01 | San Diego | Artificial intelligence |
| 96 | Xenter | Series B | $58.2M | 2026-06-30 | Draper | Hardware |
| 97 | Neusignal Therapeutics | Series B | $32.8M | 2026-06-30 | Tokyo | Biotech |
| 98 | The Indus Valley | Series B | $17.0M | 2026-06-30 | Chennai | Commerce |
| 99 | Etern | Series B | 2026-06-30 | Shanghai | Biotech | |
| 100 | Oblenio Bio | Series B | $62.0M | 2026-06-25 | Cambridge | Biotech |
Table 1. The 100 most recent rounds. Source: FundingWatcher. Data as of 23 October 2026. Base: 2,750.
Largest rounds
Largest round first
100 rows
| # | Company | Round | Amount | Date | City | Sector |
|---|---|---|---|---|---|---|
| 1 | MGI Tech | Series B | $1.0B | 2020-05-28 | Shenzhen | Biotech |
| 2 | JD Health | Series B | $830.0M | 2020-08-17 | Beijing | Commerce |
| 3 | Botamedi | Series B | $657.8M | 2022-03-23 | Gangneung | Health care |
| 4 | Kailera Therapeutics | Series B | $600.0M | 2025-10-14 | Waltham | Biotech |
| 5 | Laronde | Series B | $440.0M | 2021-08-30 | Cambridge | Biotech |
| 6 | Ollin Biosciences | Series B | $330.0M | 2026-06-24 | Austin | Biotech |
| 7 | Cardurion Pharmaceuticals | Series B | $260.0M | 2024-07-16 | Boston | Biotech |
| 8 | Kardigan | Series B | $254.0M | 2025-10-14 | South San Francisco | Biotech |
| 9 | David | Series B | $250.0M | 2026-09-02 | New York | Health care |
| 10 | Medici Brands | Series B | $250.0M | 2026-09-02 | New York | Health care |
| 11 | Mirador Therapeutics | Series B | $250.0M | 2026-01-12 | San Diego | Biotech |
| 12 | Wzhouhui.com | Series B | $245.4M | 2015-12-03 | Shenzhen | Commerce |
| 13 | AltruBio | Series B | $225.0M | 2024-05-21 | Los Altos | Biotech |
| 14 | Orna Therapeutics | Series B | $221.0M | 2022-08-16 | Watertown | Biotech |
| 15 | Elemy | Series B | $219.0M | 2021-10-06 | San Francisco | Health care |
| 16 | Metsera | Series B | $215.0M | 2024-11-13 | New York | Biotech |
| 17 | Immunai | Series B | $215.0M | 2021-10-27 | New York | Artificial intelligence |
| 18 | Upstream Bio | Series B | $200.0M | 2023-06-08 | Waltham | Biotech |
| 19 | Sironax | Series B | $200.0M | 2022-08-02 | Beijing | Biotech |
| 20 | OrbusNeich Medical | Series B | $200.0M | 2021-08-30 | Sha Tin | Health care |
| 21 | Aera Therapeutics | Series B | $193.0M | 2023-02-16 | Boston | Biotech |
| 22 | Osanni Bio | Series B | $190.0M | 2026-06-23 | San Francisco | Biotech |
| 23 | Repertoire Immune Medicines | Series B | $189.0M | 2021-04-13 | Cambridge | Biotech |
| 24 | Valgen Medtech | Series B | $188.0M | 2021-05-06 | Hangzhou | Health care |
| 25 | Tune Therapeutics | Series B | $175.0M | 2025-01-12 | Durham | Biotech |
| 26 | Aktis Oncology | Series B | $175.0M | 2024-09-30 | Boston | Biotech |
| 27 | Capstan Therapeutics | Series B | $175.0M | 2024-03-20 | San Diego | Biotech |
| 28 | Mariana Oncology | Series B | $175.0M | 2023-09-07 | Watertown | Biotech |
| 29 | Asimov | Series B | $175.0M | 2023-01-05 | Boston | Artificial intelligence |
| 30 | Haihe Biopharma | Series B | $171.0M | 2020-07-24 | Shanghai | Biotech |
| 31 | Instil Bio | Series B | $170.2M | 2020-08-03 | Dallas | Biotech |
| 32 | Barinthus Biotherapeutics | Series B | $168.0M | 2021-03-17 | Harwell | Biotech |
| 33 | Awardco | Series B | $165.0M | 2025-05-20 | Lindon | Health care |
| 34 | Windward Bio | Series B | $165.0M | 2026-05-04 | Basel | Biotech |
| 35 | Nuvig Therapeutics | Series B | $161.0M | 2024-12-05 | Redwood City | Biotech |
| 36 | Genor Biopharma | Series B | $160.0M | 2020-06-01 | Beijing | Biotech |
| 37 | Engrail Therapeutics | Series B | $157.0M | 2024-03-19 | San Diego | Biotech |
| 38 | Quell Therapeutics | Series B | $156.0M | 2021-11-29 | London | Biotech |
| 39 | AIRNA | Series B | $155.0M | 2025-04-01 | Cambridge | Biotech |
| 40 | Meiwei Dental Group | Series B | $154.3M | 2021-07-16 | Jingan | Health care |
| 41 | Strand Therapeutics | Series B | $153.0M | 2025-08-03 | Cambridge | Biotech |
| 42 | Vaderis Therapeutics | Series B | $152.0M | 2026-08-11 | Basel | Biotech |
| 43 | Matchpoint Therapeutics | Series B | $150.0M | 2026-10-07 | Cambridge | Biotech |
| 44 | Curative | Series B | $150.0M | 2025-11-28 | Austin | Fintech |
| 45 | Latigo Biotherapeutics | Series B | $150.0M | 2025-03-17 | Thousand Oaks | Biotech |
| 46 | Septerna | Series B | $150.0M | 2023-07-11 | San Francisco | Biotech |
| 47 | Alkeus Pharmaceuticals | Series B | $150.0M | 2023-06-05 | Cambridge | Biotech |
| 48 | Noah Medical | Series B | $150.0M | 2023-04-19 | San Carlos | Health care |
| 49 | MOMA Therapeutics | Series B | $150.0M | 2022-05-10 | Cambridge | Biotech |
| 50 | BostonGene | Series B | $150.0M | 2022-04-06 | Waltham | Biotech |
| 51 | JOINN Biologics | Series B | $150.0M | 2021-08-01 | Richmond | Biotech |
| 52 | WuXi Diagnostics | Series B | $150.0M | 2021-02-23 | Shanghai | Biotech |
| 53 | Visen Pharmaceuticals | Series B | $150.0M | 2021-01-08 | Shanghai | Biotech |
| 54 | Noema Pharma | Series B | $147.2M | 2024-12-11 | Basel | Biotech |
| 55 | Azafaros | Series B | $146.7M | 2025-05-13 | Leiden | Biotech |
| 56 | Zhaoke Ophthalmology Pharmaceutical | Series B | $145.0M | 2020-10-12 | Hong Kong | Biotech |
| 57 | Outpace Bio | Series B | $144.0M | 2024-08-01 | Seattle | Biotech |
| 58 | Abdera Therapeutics | Series B | $142.0M | 2023-04-20 | Vancouver | Biotech |
| 59 | AAVantgarde Bio | Series B | $141.0M | 2025-11-03 | Milan | Biotech |
| 60 | Avistone Pharmaceuticals | Series B | $140.7M | 2023-12-28 | Beijing | Biotech |
| 61 | Harbinger Health | Series B | $140.0M | 2023-09-28 | Cambridge | Artificial intelligence |
| 62 | Upstream Health | Series B | $140.0M | 2022-12-02 | Scunthorpe | Health care |
| 63 | UpStream Care | Series B | $140.0M | 2022-12-01 | Greensboro | Health care |
| 64 | RVAC Medicines | Series B | $140.0M | 2022-04-26 | Singapore | Biotech |
| 65 | Shoreline Biosciences | Series B | $140.0M | 2021-11-02 | La Jolla | Biotech |
| 66 | Sidewinder Therapeutics | Series B | $137.0M | 2026-04-08 | San Diego | Biotech |
| 67 | Preventice Solutions | Series B | $137.0M | 2020-07-15 | Houston | Health care |
| 68 | VelosBio | Series B | $137.0M | 2020-07-08 | San Diego | Biotech |
| 69 | Soufflé Therapeutics | Series B | $135.0M | 2026-10-13 | Boston | Biotech |
| 70 | Splice Bio | Series B | $135.0M | 2025-06-11 | Barcelona | Biotech |
| 71 | Chroma Medicine | Series B | $135.0M | 2023-02-28 | Cambridge | Biotech |
| 72 | Juno Therapeutics | Series B | $134.0M | 2014-08-05 | Seattle | Biotech |
| 73 | ARTBIO | Series B | $132.0M | 2025-07-29 | Cambridge | Biotech |
| 74 | Alterome Therapeutics | Series B | $132.0M | 2024-04-03 | San Diego | Biotech |
| 75 | Crystalys Therapeutics | Series B | $130.0M | 2026-07-22 | San Diego | Biotech |
| 76 | Protego Biopharma | Series B | $130.0M | 2025-12-01 | San Diego | Biotech |
| 77 | Harbor Health | Series B | $130.0M | 2025-09-09 | Austin | Health care |
| 78 | GlycoEra | Series B | $130.0M | 2025-05-27 | wädenswil-zurich | Biotech |
| 79 | Halda Therapeutics | Series B | $126.0M | 2024-08-12 | New Haven | Biotech |
| 80 | SonoThera | Series B | $125.0M | 2026-06-10 | South San Francisco | Biotech |
| 81 | Qualified Health | Series B | $125.0M | 2026-03-25 | San Carlos | Artificial intelligence |
| 82 | Diagonal Therapeutics | Series B | $125.0M | 2026-01-08 | Watertown | Biotech |
| 83 | ForSight Robotics | Series B | $125.0M | 2025-06-24 | Yoqne`am `illit | Hardware |
| 84 | Santa Ana Bio | Series B | $125.0M | 2024-06-13 | Alameda | Biotech |
| 85 | Design Therapeutics | Series B | $125.0M | 2021-01-27 | Solana Beach | Biotech |
| 86 | Flow Cannabis Co. | Series B | $125.0M | 2019-02-14 | San Francisco | Health care |
| 87 | Baraya Extended Care | Series B | $124.0M | 2025-07-15 | Riyadh | Health care |
| 88 | CREATE Medicines | Series B | $122.0M | 2026-05-14 | Cambridge | Biotech |
| 89 | General Medicine | Series B | $120.0M | 2026-10-06 | San Francisco | Health care |
| 90 | Triana Biomedicines | Series B | $120.0M | 2025-12-03 | Lexington | Biotech |
| 91 | Pelage Pharmaceuticals | Series B | $120.0M | 2025-10-15 | Los Angeles | Health care |
| 92 | Prenuvo | Series B | $120.0M | 2025-02-13 | Vancouver | Health care |
| 93 | FIRE1 | Series B | $120.0M | 2025-01-07 | Dublin | Biotech |
| 94 | Idrx | Series B | $120.0M | 2024-08-07 | Cambridge | Biotech |
| 95 | Pheon Therapeutics | Series B | $120.0M | 2024-05-21 | London | Biotech |
| 96 | OriginCell | Series B | $120.0M | 2022-08-01 | Pudong | Biotech |
| 97 | Remilk | Series B | $120.0M | 2022-01-04 | Tel Aviv | Biotech |
| 98 | Forge Medical | Series B | $120.0M | 2021-04-29 | Lancaster | Hardware |
| 99 | Anaveon | Series B | $119.7M | 2021-12-16 | Bottmingen | Health care |
| 100 | Claris Biotherapeutics | Series B | $118.0M | 2026-07-28 | Jersey City | Biotech |
Table 2. The 100 largest rounds. Source: FundingWatcher. Data as of 23 October 2026. Base: 2,750.
By month
| Month | Companies |
|---|---|
| 2024-11 | 14 |
| 2024-12 | 23 |
| 2025-01 | 22 |
| 2025-02 | 21 |
| 2025-03 | 16 |
| 2025-04 | 29 |
| 2025-05 | 34 |
| 2025-06 | 15 |
| 2025-07 | 24 |
| 2025-08 | 26 |
| 2025-09 | 29 |
| 2025-10 | 30 |
| 2025-11 | 26 |
| 2025-12 | 30 |
| 2026-01 | 40 |
| 2026-02 | 22 |
| 2026-03 | 29 |
| 2026-04 | 19 |
| 2026-05 | 17 |
| 2026-06 | 36 |
| 2026-07 | 24 |
| 2026-08 | 28 |
| 2026-09 | 28 |
| 2026-10 | 15 |
Table 3. Health care startups that raised Series B by month of the round. Source: FundingWatcher. Data as of 23 October 2026. Base: 2,750.
Country
| Country | Companies |
|---|---|
| United States | 1,291 |
| China | 657 |
| South Korea | 139 |
| United Kingdom | 96 |
| Japan | 58 |
| India | 57 |
| France | 52 |
| Israel | 52 |
| Switzerland | 50 |
| Germany | 50 |
| Canada | 40 |
| The Netherlands | 25 |
| Singapore | 19 |
| Ireland | 16 |
| Australia | 16 |
Table 4. Health care startups that raised Series B by country. Source: FundingWatcher. Data as of 23 October 2026. Base: 2,750.
City
| City | Companies |
|---|---|
| Shanghai | 104 |
| Beijing | 93 |
| San Francisco | 89 |
| New York | 87 |
| Cambridge | 75 |
| Boston | 61 |
| San Diego | 60 |
| Seoul | 57 |
| Hangzhou | 55 |
| Shenzhen | 53 |
| Suzhou | 45 |
| London | 44 |
| Seattle | 34 |
| Guangzhou | 27 |
| Nanjing | 26 |
Table 5. Health care startups that raised Series B by city. Source: FundingWatcher. Data as of 23 October 2026. Base: 2,750.
Sector
| Sector | Companies |
|---|---|
| Health care | 2,750 |
| Biotech | 1,232 |
| Software | 542 |
| Artificial intelligence | 213 |
| Hardware | 154 |
| Commerce | 91 |
| Fintech | 76 |
| Education | 35 |
| Cybersecurity | 10 |
| Energy | 6 |
Table 6. Health care startups that raised Series B by sector. Source: FundingWatcher. Data as of 23 October 2026. Base: 2,750.
Health care at other stages
Other sectors that raised Series B
software startups that raised Series B5,740
AI startups that raised Series B1,636
fintech startups that raised Series B1,501
commerce startups that raised Series B1,538
hardware startups that raised Series B2,357
biotech startups that raised Series B1,423
education startups that raised Series B488
cybersecurity startups that raised Series B643
energy startups that raised Series B512
Cite: FundingWatcher, 2,750 health care companies whose most recent round is Series B, 23 October 2026. https://fundingwatcher.com/startups/health-care/series-b/